However, cancer cells develop several mechanisms, such as downregulation of NKG2D ligands (NKG2DL), to evade the NK cell-mediated immunity (Bauman et al. 2016; Zhou et al. 2020; Peng et al. 2022). The gene discussed is KLRK1; the disease is cancer.